Medicine and Dentistry
Radioembolization
100%
Yttrium 90
91%
Hepatocellular Carcinoma
86%
Neoplasm
50%
Microsphere
42%
Transcatheter Arterial Chemoembolization
32%
Liver Tumor
20%
Inferior Vena Cava Filter
18%
Cancer
17%
Liver Metastasis
16%
Oncology
16%
Overall Survival
16%
Embolization
16%
Diseases
16%
Metastatic Carcinoma
15%
Magnetic Resonance Imaging
13%
Liver Cancer
11%
Adverse Event
11%
Perfusion Weighted Imaging
10%
Portal Vein Thrombosis
9%
Bilirubin
9%
Interventional Radiology
8%
Segmentectomy
8%
Liver Transplantation
8%
Necrosis
7%
Hepatic Portal Vein
7%
Malignant Neoplasm
7%
Computer Assisted Tomography
7%
Intraarterial Drug Administration
6%
Interventional Radiologist
6%
Colorectal Carcinoma
6%
Albumin
6%
Response Evaluation Criteria in Solid Tumors
6%
Transjugular Intrahepatic Portosystemic Shunt
5%
Colorectal Liver Metastasis
5%
Hazard Ratio
5%
Radiofrequency Ablation
5%
Liver Function
5%
Keyphrases
Hepatocellular Carcinoma
75%
Radioembolization
67%
Yttrium-90 Radioembolization
48%
Yttrium-90 Microspheres
25%
Yttrium-90
24%
Tumor
24%
Chemoembolization
22%
Liver
19%
Intra-arterial
19%
Inferior Vena Cava Filter
18%
Locoregional Therapy
16%
Transarterial Radioembolization
13%
Liver Tumor
12%
Transcatheter
12%
Magnetic Resonance Imaging
12%
Overall Survival
12%
Confidence Interval
12%
Tumor Response
10%
Transarterial Chemoembolization
10%
Adverse Events
10%
Portal Vein Thrombosis
9%
Glass Microspheres
9%
Unresectable Hepatocellular Carcinoma
8%
Liver Transplantation
8%
Radiation Segmentectomy
8%
European Association for the Study of the Liver
8%
Transcatheter Arterial Chemoembolization
8%
Hepatic Malignancy
8%
TheraSphere
7%
Necrosis
7%
Interventional Radiology
7%
Interventional Radiologist
7%
VX2 Tumor
7%
Time to Progression
7%
Perfusion Magnetic Resonance Imaging
7%
Patient Cohort
7%
Resection
7%
Interventional Oncology
7%
Transarterial
7%
Inferior Vena Cava Filter Retrieval
6%
Liver Metastasis
6%
Lobar
6%
Hepatocellular Carcinoma Patients
6%
Liver Cancer
6%
Primary Liver Cancer
6%
Imaging Response
6%
Colorectal Liver Metastases
6%
Response Evaluation Criteria in Solid Tumors (RECIST)
6%
Transjugular Intrahepatic Portosystemic Shunt
5%
World Health Organization
5%